These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1364737)

  • 1. [New studies on breast cancer to predict disease outcome and clinical use of these new tests].
    Kallioniemi OP; Holli K; Visakorpi T; Koivula T; Helin H; Isola J
    Duodecim; 1991; 107(11):907-16. PubMed ID: 1364737
    [No Abstract]   [Full Text] [Related]  

  • 2. New and old in prognosis determination.
    Vecchione A
    In Vivo; 1993; 7(6B):623-6. PubMed ID: 8193283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management?
    Narod S
    Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer and pregnancy.
    Leslie KK; Lange CA
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):547-58. PubMed ID: 16310671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA analysis of breast cancer].
    Ohuchi N; Mori S
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):30-6. PubMed ID: 1987899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of tumor marker CA15-3 in breast cancer].
    Kikuchi K; Uematsu Y; Takada Y; Kurihara E; Suito T; Fujisaki M; Takahashi R; Tamura T
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3095-100. PubMed ID: 3479052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers of breast and ovarian cancer.
    Steel CM
    Dis Markers; 1991; 9(3-4):213-23. PubMed ID: 1813211
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors in breast cancer: a brief review.
    Fernö M
    Anticancer Res; 1998; 18(3C):2167-71. PubMed ID: 9703779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in breast cancer.
    Merkel DE; Osborne CK
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental and clinical experiences with steroid hormone receptors in breast cancer].
    Jonat W
    Wien Klin Wochenschr; 1984 Jun; 96(13):499-508. PubMed ID: 6089443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
    Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive markers in breast cancer--the future.
    Faratian D; Bartlett J
    Histopathology; 2008 Jan; 52(1):91-8. PubMed ID: 18171420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.
    Ditzel HJ; Lyng MB
    Nat Clin Pract Oncol; 2008 Jul; 5(7):376-7. PubMed ID: 18506164
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
    Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
    Batabyal SK; Ghosh SN; Roy NK; Mehrotra YN; Gupta A
    Indian J Pathol Microbiol; 1987 Oct; 30(4):407-12. PubMed ID: 3507401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.